BioMarin Pharmaceutical Inc
BMRN· Nasdaq
Released Oct 31, 2017, after the close
10-Q filed Oct 31, 2017, 31 days after period end · 0001564590-17-020527
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $334.15M | $279.90M | $208.90M | $176.55M |
| Net Income | -$12.53M | -$37.43M | -$90.93M | $7.45M |
| EPS Diluted | -$0.07 |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| -$0.22 |
| -$0.60 |
| $0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.